Man­u­fac­tur­ing roundup: As­pen teams up with the Serum In­sti­tute; Por­ton se­cures sev­er­al strate­gic part­ner­ships

While South African-based man­u­fac­tur­er As­pen looks at a pos­si­ble change in di­rec­tion for pro­duc­ing Covid-19 vac­cines for the African con­ti­nent, the com­pa­ny has se­cured a new con­tract with a ma­jor vac­cine play­er.

The Serum In­sti­tute of In­dia and As­pen have en­tered in­to a 10-year agree­ment, in which As­pen will man­u­fac­ture and dis­trib­ute four of its vac­cines for the African mar­ket, with some of those vac­cines be­ing avail­able for The Serum In­sti­tute to al­so dis­trib­ute on the con­ti­nent.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER